Filing Details

Accession Number:
0001209191-13-015603
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-11 16:17:03
Reporting Period:
2013-03-08
Filing Date:
2013-03-11
Accepted Time:
2013-03-11 16:17:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1108109 Community Health Systems Inc CYH Services-General Medical & Surgical Hospitals, Nec (8062) 133893191
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1407312 Daniel Thomas Miller 4000 Meridian Boulevard
Franklin TN 37067
Division President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-03-08 53,591 $43.08 79,874 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $40.41 2008-07-25 2015-07-24 50,000 50,000 Direct
Common Stock Stock Options (Right to Buy) $32.28 2010-02-27 2019-02-26 20,000 20,000 Direct
Common Stock Stock Options (Right to Buy) $33.90 2011-02-24 2020-02-23 10,000 10,000 Direct
Common Stock Stock Options (Right to Buy) $37.96 2012-02-23 2021-02-22 10,000 10,000 Direct
Common Stock Stock Options (Right to Buy) $21.07 2013-02-16 2022-02-15 8,000 8,000 Direct
Common Stock Performance Based Restricted $0.00 2014-02-27 2023-02-26 25,000 25,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-07-24 50,000 50,000 Direct
2019-02-26 20,000 20,000 Direct
2020-02-23 10,000 10,000 Direct
2021-02-22 10,000 10,000 Direct
2022-02-15 8,000 8,000 Direct
2023-02-26 25,000 25,000 Direct
Footnotes
  1. The shares were sold in a series of transactions at a weighted average price of $43.083 per share.
  2. Each performance based restricted share represents a contingent right to receive one share of CYH common stock. There are two elements to the lapsing of the restriction; first, the Company must achieve specified targeted amount of earnings per share from continuing operations, or net revenue from continuing operations, and if the performance objective is met, the vesting restrictions will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. If the objectives are not met, the shares will be forfeited.